Nanalysis Scientific (CVE:NSCI) Stock Price Up 7.1% – Still a Buy?

Nanalysis Scientific Corp. (CVE:NSCI)’s share price shot up 7.1% on Tuesday . The stock traded as high as C$0.30 and last traded at C$0.30. 10,500 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 59,890 shares. The stock had previously closed at C$0.28.

Nanalysis Scientific Price Performance

The company has a market cap of C$32.22 million, a P/E ratio of -2.38 and a beta of 0.72. The company’s 50-day moving average price is C$0.31 and its 200-day moving average price is C$0.34. The company has a debt-to-equity ratio of 71.72, a current ratio of 1.42 and a quick ratio of 1.11.

Nanalysis Scientific Company Profile

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.